Cargando…
Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea
As of June 2022, 5 coronavirus disease 2019 (COVID-19) vaccine brands have been used in Korea’s national immunization program. The Korea Disease Control and Prevention Agency has enhanced vaccine safety monitoring through a passive web-based reporting system and active text message-based monitoring....
Autores principales: | Lee, Yeon-Kyeng, Kwon, Yunhyung, Heo, Yesul, Kim, Eun Kyoung, Kim, Seung Yun, Cho, Hoon, Kim, Seontae, Ko, Mijeong, Lim, Dosang, Seo, Soon-Young, Cho, Enhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556797/ https://www.ncbi.nlm.nih.gov/pubmed/37309116 http://dx.doi.org/10.3345/cep.2022.00815 |
Ejemplares similares
-
Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
por: Kwon, Yunhyung, et al.
Publicado: (2022) -
COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021
por: Hwang, Insob, et al.
Publicado: (2021) -
Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over
por: Kim, Seontae, et al.
Publicado: (2023) -
Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea
por: Kim, Seontae, et al.
Publicado: (2022) -
COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021
por: Oh, Hyun-kyung, et al.
Publicado: (2021)